news Improving the effectiveness of immunotherapy for glioblastoma 2 August 2024 | By Drug Target Review Researchers utilised AI to identify genes that reprogramme GBM cancer cells into dendritic cells within the tumour.
news Scientists identify therapeutic targets to overcome radioresistance of brain cancer cells 20 January 2023 | By Ria Kakkad (Drug Target Review) A new drug could replace the current standard for treating radioresistance brain cancer by sensitising the cancer cells to radiotherapy.
news Novel cancer vaccine simultaneously kills and prevents brain cancer 5 January 2023 | By Izzy Wood (Drug Target Review) US researchers develop a dual-action cell therapy engineered to eliminate established tumours and train the immune system to eradicate primary tumour and prevent cancer’s recurrence.
news New drug could be used for targeted cancer therapies 7 August 2019 | By Rachael Harper (Drug Target Review) A new drug called IP1867B, which could be used for future treatments of brain tumours, is being examined.